Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

0.6499
Delayed Data
As of 3:59pm ET
 +0.1439 / +28.44%
Today’s Change
0.44
Today|||52-Week Range
1.55
-27.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues3.8M8.0M5.7M3.1M
 
 
 
 
 
Depreciation And Amortization31.0K20.0K29.0K27.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.7M------
 
 
General Expenses38.3M39.7M50.7M42.3M
 
 
 
 
 
Research And Development29.2M28.9M27.7M23.7M
 
 
 
 
 
Total Operating Expenses38.4M39.7M50.8M42.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-34.6M-31.8M-45.0M-39.3M
 
 
 
 
 
Extraordinary Credit0.0096.0K3.9M3.5M
 
 
 
 
Extraordinary Charge-7.5M0.00--0.00
 
 
Interest Expense On Debt1.9M2.9M1.7M939.0K
 
 
 
 
 
Other Expenses10.0K-4.0K-132.0K22.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.0M-34.6M-43.0M-36.7M
 
 
 
 
 
Net Income-44.0M-34.6M-43.0M-36.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.1M52.2M60.1M72.9M
 
 
 
 
 
Shares To Calculate EPS Diluted48.1M52.2M61.5M72.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.91-$0.66-$0.76-$0.50
 
 
 
 
 
EPS Diluted-$0.91-$0.66-$0.76-$0.50